Viskase Holdings Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

91.40M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	26.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	26.00K	-675.00K	-96.29%
Dec 31, 2021	701.00K	649.00K	1,248.08%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Vaxart	237.26M
BioStem Technologies	47.48M
Nuo Therapeutics	3.31M
Harvard Apparatus Regenerative Technology	704.00K
Provectus Biopharmaceuticals	336.11K

Revenue Rankings

Viskase Holdings News

5 weeks ago - Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock - GlobeNewsWire
5 weeks ago - Enzon Announces Reverse Stock Split - GlobeNewsWire
6 weeks ago - Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock - GlobeNewsWire
3 months ago - Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger - GlobeNewsWire
6 months ago - Enzon and Viskase Announce Amendment to Merger Agreement - GlobeNewsWire
11 months ago - Enzon and Viskase Enter into Merger Agreement - GlobeNewsWire
5 years ago - Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon's CFO, to Assume Position of CEO and Remain CFO - GlobeNewsWire
6 years ago - Enzon Pharmaceuticals Announces Results of Rights Offering - GlobeNewsWire

More News